CDX2 is highly expressed in various gastrointestinal cancers, such as colorectal adenocarcinomas (70–85%), gastroesophageal (50%), stomach (55–70%), ampulla (65–80%) and small intestine tumors (60%) [20, 46]. The gene discussed is CDX2; the disease is colorectal adenocarcinoma.